Vayres, France

Francois Godart

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 4(Granted Patents)


Location History:

  • Genissac, FR (2017)
  • Vayres, FR (2018)

Company Filing History:


Years Active: 2017-2025

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovations of Francois Godart

Introduction

Francois Godart is a notable inventor based in Vayres, France. He has made significant contributions to the field of biotechnology, particularly in the production of docosahexaenoic acid (DHA) through innovative methods involving microorganisms. With a total of five patents to his name, Godart's work has implications for both human and animal nutrition.

Latest Patents

One of his latest patents is focused on an oil of microorganisms rich in docosahexaenoic acid. This invention relates to an oil that comprises more than 60% DHA relative to the total mass of fat. It is particularly useful for human or animal feed, especially for infants, children, and pregnant or lactating women. Another significant patent involves a method for culturing microalgae of the Aurantiochytrium genus in a culture medium devoid of chloride and sodium. This method allows for high biomass yield and lipid enrichment, specifically enhancing the production of DHA.

Career Highlights

Francois Godart is currently associated with Fermentalg, a company that specializes in the production of microalgae-based products. His work at Fermentalg has been pivotal in advancing the understanding and application of DHA in various nutritional contexts.

Collaborations

He has collaborated with notable colleagues such as Pierre Calleja and Julien Pagliardini, contributing to the innovative research and development within the company.

Conclusion

Francois Godart's contributions to the field of biotechnology through his patents and work at Fermentalg highlight the importance of innovation in nutritional science. His inventions pave the way for healthier feeding options for vulnerable populations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…